l-Serine synthesis in the central nervous system: A review on serine deficiency disorders

Molecular Genetics and Metabolism

Volumn 99, Issue 3, 2010, Pages 256-262

  Tabatabaie, L ^a   Klomp, L W ^a   Berger, R ^a   de Koning, T J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

3 PGDH deficiency; d Serine; l Serine; PSAT deficiency; PSPH deficiency

Indexed keywords

AMINOTRANSFERASE; GLYCINE; PHOSPHATASE; PHOSPHOGLYCERATE DEHYDROGENASE; PHOSPHOSERINE AMINOTRANSFERASE; PHOSPHOSERINE PHOSPHATASE; SERINE; UNCLASSIFIED DRUG;

AMINO ACID DEFICIENCY; AMINO ACID SYNTHESIS; BIOSYNTHESIS; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; GENE MUTATION; GENETIC DISORDER; GLUCONEOGENESIS; METABOLITE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SERINE DEFICIENCY;

AMINO ACID METABOLISM, INBORN ERRORS; ANIMALS; BRAIN; BRAIN DISEASES, METABOLIC, INBORN; CENTRAL NERVOUS SYSTEM; HUMANS; MICE; MUTATION; PHOSPHOGLYCERATE DEHYDROGENASE; PHOSPHORIC MONOESTER HYDROLASES; RATS; SERINE; SYNDROME; TRANSAMINASES;

EID: 76349118741     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.10.012     Document Type: Review

References (105)

1. Furuya S., Yoshida K., Kawakami Y., et al. Inactivation of the 3-phosphoglycerate dehydrogenase gene in mice: changes in gene expression and associated regulatory networks resulting from serine deficiency. Funct. Integr. Genomics (2008)
2. Mothet J.P., Parent A.T., Wolosker H., et al. d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. USA 97 (2000) 4926-4931
3. Schell M.J., Brady Jr. R.O., Molliver M.E., et al. d-Serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J. Neurosci. 17 (1997) 1604-1615
4. Yoshida K., Furuya S., Osuka S., et al. Targeted disruption of the mouse 3-phosphoglycerate dehydrogenase gene causes severe neurodevelopmental defects and results in embryonic lethality. J. Biol. Chem. 279 (2004) 3573-3577
5. Yamasaki M., Yamada K., Furuya S., et al. 3-Phosphoglycerate dehydrogenase, a key enzyme for l-serine biosynthesis, is preferentially expressed in the radial glia/astrocyte lineage and olfactory ensheathing glia in the mouse brain. J. Neurosci. 21 (2001) 7691-7704
6. Ichihara A., and Greenberg D.M. Pathway of serine formation from carbohydrate in rat liver. Proc. Natl. Acad. Sci. USA 41 (1955) 605-609
7. Snell K. Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv. Enzyme Regul. 22 (1984) 325-400
8. Cheung G.P., Cotropia J.P., and Sallach H.J. The effects of dietary protein on the hepatic enzymes of serine metabolism in the rabbit. Arch. Biochem. Biophys. 129 (1969) 672-682
9. Rowsell E.V., Snell K., Carnie J.A., et al. Liver-l-alanine-glyoxylate and l-serine-pyruvate aminotransferase activities: an apparent association with gluconeogenesis. Biochem. J. 115 (1969) 1071-1073
10. Lowry M., Hall D.E., Hall M.S., et al. Renal metabolism of amino acids in vivo: studies on serine and glycine fluxes. Am. J. Physiol. 252 (1987) F304-F309
11. Grant G.A., and Bradshaw R.A. d-3-Phosphoglycerate dehydrogenase from chicken liver. II. Chemical and physical properties. J. Biol. Chem. 253 (1978) 2727-2731
12. Grant G.A., Keefer L.M., and Bradshaw R.A. d-3-Phosphoglycerate dehydrogenase from chicken liver. I. Purification. J. Biol. Chem. 253 (1978) 2724-2726
13. Grant G.A. A new family of 2-hydroxyacid dehydrogenases. Biochem. Biophys. Res. Commun. 165 (1989) 1371-1374
14. Lamzin V.S., Dauter Z., Popov V.O., et al. High resolution structures of holo and apo formate dehydrogenase. J. Mol. Biol. 236 (1994) 759-785
15. Goldberg J.D., Yoshida T., and Brick P. Crystal structure of a NAD-dependent d-glycerate dehydrogenase at 2.4 Å resolution. J. Mol. Biol. 236 (1994) 1123-1140
16. Grant G.A., and Zapp M.L. d-3-phosphoglycerate dehydrogenase from Escherichia coli: isolation by affinity chromatography and sequence comparison to other dehydrogenases. Biosci. Rep. 1 (1981) 733-741
17. Saski R., and Pizer L.I. Regulatory properties of purified 3-phosphoglycerate dehydrogenase from Bacillus subtilis. Eur. J. Biochem. 51 (1975) 415-427
18. Sugimoto E., and Pizer L.I. The mechanism of end product inhibition of serine biosynthesis. I. Purification and kinetics of phosphoglycerate dehydrogenase. J. Biol. Chem. 243 (1968) 2081-2089
19. Tobey K.L., and Grant G.A. The nucleotide sequence of the serA gene of Escherichia coli and the amino acid sequence of the encoded protein, d-3-phosphoglycerate dehydrogenase. J. Biol. Chem. 261 (1986) 12179-12183
20. Albers E., Laize V., Blomberg A., et al. Ser3p (Yer081wp) and Ser33p (Yil074cp) are phosphoglycerate dehydrogenases in Saccharomyces cerevisiae. J. Biol. Chem. 278 (2003) 10264-10272
21. Slaughter J.C., and Davies D.D. The isolation and characterization of 3-phosphoglycerate dehydrogenase from peas. Biochem. J. 109 (1968) 743-748
22. Slaughter J.C., and Davies D.D. 3-Phosphoglycerate dehydrogenase from seedlings of Pisum sativum. Methods Enzymol. 41 (1975) 278-281
23. Walsh D.A., and Sallach H.J. Purification and properties of chicken liver d-3-phosphoglycerate dehydrogenase. Biochemistry 4 (1965) 1076-1085
24. Walsh D.A., and Sallach H.J. d-3-Phosphoglycerate dehydrogenase. Further studies on the enzyme isolated from chicken liver. Biochim. Biophys. Acta 146 (1967) 26-34
25. Achouri Y., Rider M.H., Schaftingen E.V., et al. Cloning, sequencing and expression of rat liver 3-phosphoglycerate dehydrogenase. Biochem. J. 323 Pt 2 (1997) 365-370
26. Cho H.M., Jun D.Y., Bae M.A., et al. Nucleotide sequence and differential expression of the human 3-phosphoglycerate dehydrogenase gene. Gene 245 (2000) 193-201
27. Lund K., Merrill D.K., and Guynn R.W. Purification and subunit structure of phosphoglycerate dehydrogenase from rabbit liver. Biochem. J. 238 (1986) 919-922
28. Al-Rabiee R., Lee E.J., and Grant G.A. The mechanism of velocity modulated allosteric regulation in d-3-phosphoglycerate dehydrogenase. Cross-linking adjacent regulatory domains with engineered disulfides mimics effector binding. J. Biol. Chem. 271 (1996) 13013-13017
29. Al-Rabiee R., Zhang Y., and Grant G.A. The mechanism of velocity modulated allosteric regulation in d-3-phosphoglycerate dehydrogenase. Site-directed mutagenesis of effector binding site residues. J. Biol. Chem. 271 (1996) 23235-23238
30. max-type allosteric enzyme. Protein Sci. 5 (1996) 34-41
31. Grant G.A., Xu X.L., Hu Z., et al. Phosphate ion partially relieves the cooperativity of effector binding in d-3-phosphoglycerate dehydrogenase without altering the cooperativity of inhibition. Biochemistry 38 (1999) 16548-16552
32. Grant G.A., Kim S.J., Xu X.L., et al. The contribution of adjacent subunits to the active sites of d-3-phosphoglycerate dehydrogenase. J. Biol. Chem. 274 (1999) 5357-5361
33. Grant G.A., Xu X.L., and Hu Z. Removal of the tryptophan 139 side chain in Escherichia coli d-3-phosphoglycerate dehydrogenase produces a dimeric enzyme without cooperative effects. Arch. Biochem. Biophys. 375 (2000) 171-174
34. Grant G.A., Hu Z., and Xu X.L. Amino acid residue mutations uncouple cooperative effects in Escherichia coli d-3-phosphoglycerate dehydrogenase. J. Biol. Chem. 276 (2001) 17844-17850
35. Schuller D.J., Fetter C.H., and Banaszak L.J. Et al. Enhanced expression of the Escherichia coli serA gene in a plasmid vector. Purification, crystallization, and preliminary X-ray data of d-3 phosphoglycerate dehydrogenase. J. Biol. Chem. 264 (1989) 2645-2648
36. max-type cooperative enzyme phosphoglycerate dehydrogenase. Nat. Struct. Biol. 2 (1995) 69-76
37. Winicov I., and Pizer L.I. The mechanism of end product inhibition of serine biosynthesis. IV. Subunit structure of phosphoglycerate dehydrogenase and steady state kinetic studies of phosphoglycerate oxidation. J. Biol. Chem. 249 (1974) 1348-1355
38. Rosenbloom J. The mechanism of end product inhibition of serine biosynthesis. 3. Physical and chemical properties of phosphoglycerate dehydrogenase. J. Biol. Chem. 243 (1968) 2099-2107
39. Dey S., Grant G.A., and Sacchettini J.C. Crystal structure of Mycobacterium tuberculosis d-3-phosphoglycerate dehydrogenase: extreme asymmetry in a tetramer of identical subunits. J. Biol. Chem. 280 (2005) 14892-14899
40. Dey S., Hu Z., Xu X.L., et al. d-3-Phosphoglycerate dehydrogenase from Mycobacterium tuberculosis is a link between the Escherichia coli and mammalian enzymes. J. Biol. Chem. 280 (2005) 14884-14891
41. Dey S., Burton R.L., Grant G.A., et al. Structural analysis of substrate and effector binding in Mycobacterium tuberculosis d-3-phosphoglycerate dehydrogenase. Biochemistry 47 (2008) 8271-8282
42. max regulation through domain and subunit changes. The active form of phosphoglycerate dehydrogenase. Biochemistry 44 (2005) 5763-5773
43. Battchikova N., Himanen J.P., Ahjolahti M., et al. Phosphoserine aminotransferase from Bacillus circulans subsp. alkalophilus: purification, gene cloning and sequencing. Biochim. Biophys. Acta 1295 (1996) 187-194
44. Hester G., Stark W., and Moser M. Et al. Crystal structure of phosphoserine aminotransferase from Escherichia coli at 2.3 Å resolution: comparison of the unligated enzyme and a complex with alpha-methyl-l-glutamate. J. Mol. Biol. 286 (1999) 829-850
45. Belhumeur P., Fortin N., and Clark M.W. A gene from Saccharomyces cerevisiae which codes for a protein with significant homology to the bacterial 3-phosphoserine aminotransferase. Yeast 10 (1994) 385-389
46. Ho C.L., Noji M., Saito M., et al. Molecular characterization of plastidic phosphoserine aminotransferase in serine biosynthesis from Arabidopsis. Plant. J. 16 (1998) 443-452
47. Saito K., Takagi Y., Ling H.C., et al. Molecular cloning, characterization and expression of cDNA encoding phosphoserine aminotransferase involved in phosphorylated pathway of serine biosynthesis from spinach. Plant. Mol. Biol. 33 (1997) 359-366
48. Hirsch H., and Greenberg D.M. Studies on phosphoserine aminotransferase of sheep brain. J. Biol. Chem. 242 (1967) 2283-2287
49. Lund K., Merrill D.K., and Guynn R.W. Purification and properties of phosphoserine aminotransferase from bovine liver. Arch. Biochem. Biophys. 254 (1987) 319-328
50. Baek J.Y., Jun D.Y., Taub D., et al. Characterization of human phosphoserine aminotransferase involved in the phosphorylated pathway of l-serine biosynthesis. Biochem. J. 373 (2003) 191-200
51. Wang W., Kim R., Jancarik J., et al. Crystal structure of phosphoserine phosphatase from Methanococcus jannaschii, a hyperthermophile, at 1.8 Å resolution. Structure 9 (2001) 65-71
52. Wang W., Cho H.S., Kim R., et al. Structural characterization of the reaction pathway in phosphoserine phosphatase: crystallographic "snapshots" of intermediate states. J. Mol. Biol. 319 (2002) 421-431
53. Peeraer Y., Rabijns A., Verboven C., et al. Purification, crystallization and preliminary X-ray diffraction analysis of human phosphoserine phosphatase. Acta Crystallogr. D Biol. Crystallogr. 58 (2002) 133-134
54. Peeraer Y., Rabijns A., Collet J.F., et al. How calcium inhibits the magnesium-dependent enzyme human phosphoserine phosphatase. Eur. J. Biochem. 271 (2004) 3421-3427
55. Monod J., Changeux J.P., and Jacob F. Allosteric proteins and cellular control systems. J. Mol. Biol. 6 (1963) 306-329
56. Umbarger H.E., and Umbarger M.A. The biosynthetic pathway of serine in Salmonella typhimurium. Biochim. Biophys. Acta 62 (1962) 193-195
57. Pizer L.I. The pathway and control of serine biosynthesis in Escherichia coli. J. Biol. Chem. 238 (1963) 3934-3944
58. Slaughter J.C., and Davies D.D. Inhibition of 3-phosphoglycerate dehydrogenase by l-serine. Biochem. J. 109 (1968) 749-755
59. Fell D.A., and Snell K. Control analysis of mammalian serine biosynthesis. Feedback inhibition on the final step. Biochem. J. 256 (1988) 97-101
60. Hawkinson J.E., Costa-Burruel M., Ta N.D., et al. Novel phosphoserine phosphatase inhibitors. Eur. J. Pharmacol. 337 (1997) 315-324
61. Furuya S., Tabata T., Mitoma J., et al. l-Serine and glycine serve as major astroglia-derived trophic factors for cerebellar Purkinje neurons. Proc. Natl. Acad. Sci. USA 97 (2000) 11528-11533
62. Mitoma J., Furuya S., and Hirabayashi Y. A novel metabolic communication between neurons and astrocytes: non-essential amino acid l-serine released from astrocytes is essential for developing hippocampal neurons. Neurosci. Res. 30 (1998) 195-199
63. Wade L.A., and Brady H.M. Cysteine and cystine transport at the blood-brain barrier. J. Neurochem. 37 (1981) 730-734
64. Lefauconnier J.M., and Trouve R. Developmental changes in the pattern of amino acid transport at the blood-brain barrier in rats. Brain Res. 282 (1983) 175-182
65. Hawkins R.A., O'Kane R.L., Simpson I.A., et al. Structure of the blood-brain barrier and its role in the transport of amino acids. J. Nutr. 136 (2006) 218S-226S
66. Hawkins R.A., Mans A.M., Hibbard L.S., et al. Regional transport of some essential nutrients across the blood-brain barrier in normal and diseased states. Ann. N.Y. Acad. Sci. 529 (1988) 40-49
67. Verleysdonk S., Martin H., Willker W., et al. Rapid uptake and degradation of glycine by astroglial cells in culture: synthesis and release of serine and lactate. Glia 27 (1999) 239-248
68. Johnson J.W., and Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325 (1987) 529-531
69. Kleckner N.W., and Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241 (1988) 835-837
70. Hashimoto A., Nishikawa T., Oka T., et al. Endogenous d-serine in rat brain: N-methyl-d-aspartate receptor-related distribution and aging. J. Neurochem. 60 (1993) 783-786
71. Wolosker H., Blackshaw S., and Snyder S.H. Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate-N-methyl-d-aspartate neurotransmission. Proc. Natl. Acad. Sci. USA 96 (1999) 13409-13414
72. Wolosker H., Sheth K.N., Takahashi M., et al. Purification of serine racemase: biosynthesis of the neuromodulator d-serine. Proc. Natl. Acad. Sci. USA 96 (1999) 721-725
73. Wolosker H., Panizzutti R., and De M.J. Neurobiology through the looking-glass: d-serine as a new glial-derived transmitter. Neurochem. Int. 41 (2002) 327-332
74. Wolosker H. d-Serine regulation of NMDA receptor activity. Sci. STKE 2006 (2006) e41
75. Panizzutti R., De M.J., Ribeiro C.S., et al. A new strategy to decrease N-methyl-d-aspartate (NMDA) receptor coactivation: inhibition of d-serine synthesis by converting serine racemase into an eliminase. Proc. Natl. Acad. Sci. USA 98 (2001) 5294-5299
76. Inoue R., Hashimoto K., Harai T., et al. NMDA- and beta-amyloid1-42-induced neurotoxicity is attenuated in serine racemase knock-out mice. J. Neurosci. 28 (2008) 14486-14491
77. Basu A.C., Tsai G.E., Ma C.L., Ehmsen J.T., Mustafa A.K., Han L., Jiang Z.I., Benneyworth M.A., Froimowitz M.P., Lange N., Snyder S.H., Bergeron R., and Coyle J.T. Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol. Psychiatry 14 (2009) 719-727
78. Snyder S.H., and Ferris C.D. Novel neurotransmitters and their neuropsychiatric relevance. Am. J. Psychiatry 157 (2000) 1738-1751
79. Snyder S.H., and Kim P.M. d-Amino acids as putative neurotransmitters: focus on d-serine. Neurochem. Res. 25 (2000) 553-560
80. Hashimoto A., Kumashiro S., Nishikawa T., et al. Embryonic development and postnatal changes in free d-aspartate and d-serine in the human prefrontal cortex. J. Neurochem. 61 (1993) 348-351
81. Hashimoto A., Nishikawa T., Konno R., et al. Free d-serine, d-aspartate and d-alanine in central nervous system and serum in mutant mice lacking d-amino acid oxidase. Neurosci. Lett. 152 (1993) 33-36
82. Hashimoto A., Yoshikawa M., Niwa A., et al. Mice lacking d-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801. Brain Res. 1033 (2005) 210-215
83. Choi D.W., and Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13 (1990) 171-182
84. Inuzuka M., Hayakawa M., and Ingi T. Serinc, an activity-regulated protein family, incorporates serine into membrane lipid synthesis. J. Biol. Chem. 280 (2005) 35776-35783
85. Kawakami Y., Yoshida K., Yang J.H., et al. Impaired neurogenesis in embryonic spinal cord of Phgdh knockout mice, a serine deficiency disorder model. Neurosci. Res. 63 (2009) 184-193
86. Nakano I., Dougherty J.D., Kim K., et al. Phosphoserine phosphatase is expressed in the neural stem cell niche and regulates neural stem and progenitor cell proliferation. Stem Cells 25 (2007) 1975-1984
87. Buchman J.J., and Tsai L.H. Spindle regulation in neural precursors of flies and mammals. Nat. Rev. Neurosci. 8 (2007) 89-100
88. Ohnuma S., and Harris W.A. Neurogenesis and the cell cycle. Neuron 40 (2003) 199-208
89. Komuro H., and Rakic P. Selective role of N-type calcium channels in neuronal migration. Science 257 (1992) 806-809
90. Komuro H., and Rakic P. Modulation of neuronal migration by NMDA receptors. Science 260 (1993) 95-97
91. Kim P.M., Aizawa H., Kim P.S., et al. Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration. Proc. Natl. Acad. Sci. USA 102 (2005) 2105-2110
92. Fuchs S.A., Dorland L., der Velden M.G., et al. d-Serine in the developing human central nervous system. Ann. Neurol. 60 (2006) 476-480
93. Jaeken J., Detheux M., Van M.L., et al. 3-Phosphoglycerate dehydrogenase deficiency: an inborn error of serine biosynthesis. Arch. Dis. Child 74 (1996) 542-545
94. Hausler M.G., Jaeken J., Monch E., et al. Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings. Neuropediatrics 32 (2001) 191-195
95. Klomp L.W., de Koning T.J., Malingre H.E., et al. Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency-a neurometabolic disorder associated with reduced l-serine biosynthesis. Am. J. Hum. Genet. 67 (2000) 1389-1399
96. Pind S., Slominski E., Mauthe J., et al. V490M, a common mutation in 3-phosphoglycerate dehydrogenase deficiency, causes enzyme deficiency by decreasing the yield of mature enzyme. J. Biol. Chem. 277 (2002) 7136-7143
97. Pineda M., Vilaseca M.A., Artuch R., et al. 3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome. Dev. Med. Child Neurol. 42 (2000) 629-633
98. Tabatabaie L., de Koning T.J., Geboers A.J., et al. Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics. Hum. Mutat. 30 (2009) 749-756
99. de Koning T.J., Jaeken J., Pineda M., et al. Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. Neuropediatrics 31 (2000) 287-292
100. de Koning T.J., Duran M., Van M.L., et al. Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids. J. Inherit. Metab. Dis. 25 (2002) 119-125
101. de Koning T.J. Treatment with amino acids in serine deficiency disorders. J. Inherit. Metab. Dis. 29 (2006) 347-351
102. de Koning T.J., Klomp L.W., van Oppen A.C., et al. Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency. Lancet 364 (2004) 2221-2222
103. Hart C.E., Race V., Achouri Y., et al. Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway. Am. J. Hum. Genet. 80 (2007) 931-937
104. Jaeken J., Detheux M., Fryns J.P., et al. Phosphoserine phosphatase deficiency in a patient with Williams syndrome. J. Med. Genet. 34 (1997) 594-596
105. Veiga-da-Cunha M., Collet J.F., Prieur B., et al. Mutations responsible for 3-phosphoserine phosphatase deficiency. Eur. J. Hum. Genet. 12 (2004) 163-166